Business and Management

Damages And Compensation From Zantac Ranitidine Cancer Lawsuits

Sanofi and Boehringer-Ingelheim, makers of the brand-name medication, were sued in California. Plaintiffs allege that the companies manufactured a drug and sold it to the public knowing or having to know that it contained NDMA, which is a well-known carcinogen.

It is not clear what caused the drug to become contaminated. However, Stanford research suggests that the main ingredient may be broken down and form NDMA in the digestive process. The study found that people who had taken the drug had higher levels of NDMA urine. 

The legal theory of product liability is the basis for any lawsuit against drug manufacturers. When drugs are dangerous or seriously injure patients, drugmakers can be held liable. People can sue these drugmakers and others to recover damages for their injuries straight from the source.

Nexium, Prilosec Lawsuits

Image Source: Google

The Zantac trial science will hinge on the NDMA breakdown. Currently, the NDMA can be created in many ways.

  • During the Manufacturing
  • When being shipped and stored
  • During digestion and absorption, the body is responsible

A case's available compensation will depend on its facts, circumstances, the extent of injuries, and loss. Each case will be carefully reviewed by an attorney to determine its potential value and merits. People may be able to seek compensation for economic or non-economic losses by filing dangerous drug lawsuits. Economic damages include actual monetary loss for the following:

  • Past medical expenses for treating the injuries
  • Future medical and rehabilitation costs
  • Past lost wages
  • Future income loss estimates

It is more difficult to value noneconomic losses. These include:

  • Physical pain and suffering
  • Anguishment mental or emotional
  • Scarring and disfigurement
  • Reduced quality of life
  • Disability